Niti Goel

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

Roy Fleischmann, Jiří Vencovský, Ronald van Vollenhoven et al. · Annals of the Rheumatic Diseases · 2008 · 333 citations · Full text

Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course

Graciela S. Alarc�n, Jeffrey M. Roseman, Alfred A. Bartolucci et al. · Arthritis & Rheumatism · 1998 · 206 citations

Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors

Terry A. McNearney, John D. Reveille, Michael A. Fischbach et al. · Arthritis Care & Research · 2007 · 202 citations

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016

Ana‐Maria Orbai, Maarten de Wit, Philip J. Mease et al. · The Journal of Rheumatology · 2017 · 131 citations · Full text

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study

M. Weinblatt, Roy Fleischmann, T. Huizinga et al. · Lara D. Veeken · 2012 · 120 citations · Full text